公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2022 | Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis | TUNG-HUNG SU ; Peng, Cheng-Yuan; Chang, Shan-Han; TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; CHEN-HUA LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 11 | 10 | |
2018 | Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B | Papatheodoridis G.V.; Manolakopoulos S; TUNG-HUNG SU ; Siakavellas S; CHUN-JEN LIU ; Kourikou A; HUNG-CHIH YANG ; JIA-HORNG KAO | Hepatology | 45 | 39 | |
2009 | Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation | HUNG-CHIH YANG ; Xing S; Shan L; O'Connell K; Dinoso J; Shen A; Zhou Y; Shrum C.K; Han Y; Liu J.O; Zhang H; Margolick J.B; Siliciano R.F. | Journal of Clinical Investigation | 227 | 209 | |
2019 | Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection | CHEN-HUA LIU ; TUNG-HUNG SU ; CHUN-JEN LIU ; CHUN-MING HONG ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 14 | 15 | |
2018 | Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection | CHEN-HUA LIU ; YIH-SHARNG CHEN ; SHOEI-SHEN WANG ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical Infectious Diseases | 26 | 21 | |
2015 | Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition | TUNG-HUNG SU ; Shiau C.-W; Jao P; CHEN-HUA LIU ; CHUN-JEN LIU ; Tai W.-T; YUNG-MING JENG ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; HSIANG-PO HUANG ; Cheng H.-R; PEI-JER CHEN ; Chen K.-F; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 65 | 62 | |
2017 | Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis | TUNG-HUNG SU ; Shiau C.-W; Jao P; Yang N.-J; Tai W.-T; CHUN-JEN LIU ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHEN-HUA LIU ; KAI-WEN HUANG ; Hu T.-C; Huang Y.-J; YAO-MING WU ; Chen L.-J; PEI-JER CHEN ; DING-SHINN CHEN ; Chen K.-F; JIA-HORNG KAO | Scientific Reports | 12 | 11 | |
2012 | Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation | Shan L; Deng K; Shroff N.S; Durand C.M; Rabi S.A; HUNG-CHIH YANG ; Zhang H; Margolick J.B; Blankson J.N; Siliciano R.F. | Immunity | 607 | 589 | |
2013 | Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up | Yu M.-L.; Lee C.-M; CHI-LING CHEN ; Chuang W.-L; Lu S.-N; CHEN-HUA LIU ; Wu S.-S; Liao L.-Y; Kuo H.-T; Chao Y.-C; Tung S.-Y; Yang S.-S; JIA-HORNG KAO ; Su W.-W; Lin C.-L; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Hepatology | 65 | 59 | |
2024 | Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy | Chang, Kai-Chun; TUNG-HUNG SU ; SIH-HAN LIAO ; TAI-CHUNG TSENG ; SHANG-CHIN HUANG ; SHIH-JER HSU ; CHUN-MING HONG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | | | |
2020 | Towards elimination of viral hepatitis in Taiwan by 2025: In memory of Professor Ding-Shinn Chen (1943-2020) | HUNG-CHIH YANG ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 3 | 2 | |
2017 | Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection | Shan L; Deng K; Gao H; Xing S; Capoferri A.A; Durand C.M; Rabi S.A; Laird G.M; Kim M; Hosmane N.N; HUNG-CHIH YANG ; Zhang H; Margolick J.B; Li L; Cai W; Ke R; Flavell R.A; Siliciano J.D; Siliciano R.F. | Immunity | 128 | 118 | |
2008 | Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor | Bailey J.R; O'Connell K; HUNG-CHIH YANG ; Han Y; Xu J; Jilek B; Williams T.M; Ray S.C; Siliciano R.F; Blankson J.N. | Journal of Virology | 89 | 86 | |
2022 | Transporter Genes and fosA Associated With Fosfomycin Resistance in Carbapenem-Resistant Klebsiella pneumoniae | Wang, Yu-Ping; Chen, Yen-Hao; Hung, I-Cheng; Chu, Po-Hsun; Chang, Yu-Han; Lin, Yi-Tsung; HUNG-CHIH YANG ; JIN-TOWN WANG | Frontiers in microbiology | 9 | 8 | |
2014 | Unique characteristics of histone deacetylase inhibitors in reactivation of latent HIV-1 in Bcl-2-transduced primary resting CD4+ Tcells | Shan L; Xing S; HUNG-CHIH YANG ; Zhang H; Margolick J.B; Siliciano R.F. | Journal of Antimicrobial Chemotherapy | 22 | 22 | |
2018 | Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection | Lin, Pin-Hung; Wong, Weng-In; Wang, Yi-Lan; Hsieh, Meng-Ping; CHIA-WEN LU ; Liang, Chieh-Yu; Jui, Sung-Hsiang; Wu, Fang-Yi; PEI-JER CHEN ; HUNG-CHIH YANG | Mucosal Immunology | 36 | 34 | |
2021 | Viral and host factors affecting disease progression of hepatitis B virus infection | HUNG-CHIH YANG ; TUNG-HUNG SU | Hepatitis B Virus and Liver Disease | | | |
2018 | Viral factors affecting disease progression | HUNG-CHIH YANG | Hepatitis B Virus and Liver Disease | 1 | 0 | |
2017 | Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B | HUNG-CHIH YANG ; Shih Y.-F; CHUN-JEN LIU | Journal of Infectious Diseases | 7 | 7 | |
2015 | Viral hepatitis: HBV cure-can we pin our hopes on immunotherapy? | HUNG-CHIH YANG ; JIA-HORNG KAO | Nature Reviews Gastroenterology and Hepatology | 28 | 22 | |